Rena, G., Hardie, D.G. and Pearson, E.R. (2017).The mechanisms of actionof metformin. Diabetologia.17:42-27.
Rice,
S., Pellatt, L. and Ramanathan, K.(2009).Metformin inhibits aromatase
via an extracellular signal-regulated kinase-mediated pathway.
Endocrinology. 150: 4794-801.
Richy, F.F., Sabido-Espin, M., Guedes,
S., Corvino, F.A and .Gottwald-Hostalek, U. (2014). Incidence of lactic
acidosis in patients with type2 diabetes with and without renal
impairment treated with metformin:A retrospective cohort study. Diabetes
Care.37:2291–2295.
Rosen, E.D. (2012). Low testosterone in Type 2 Diabetes: A hidden epidemic. Diabetes. 12:23-24.
Rothe,
U., Müller, G., Schwarz, P.E., Seifert, M., Kunath, H., Koch, R.,
Bergmann, S., Julius, U., Bornstein, S.R., Hanefeld, M. and Schulze, J.
(2008).Evaluation of a diabetes management system based on practice
guidelines, integrated care, and continuous quality management in a
Federal State of Germany: a population-based approach to health care
research. Diabetes. Care.31(5):863-868.
Rother, K.I. (2007). Diabetes treatment-bridging the divide. New England Journal of Medicine. 356:1499-1501.
Russell-Jones,
D., Cuddihy, R.M. and Hanefeld, M.(2012).Efficacy and safety of
exenatide once weekly versus metformin, pioglitazone, and sitagliptin
used as monotherapy in drug-naive patients with type 2 diabetes
(DURATION-4): a 26-week double-blind study. Diabetes Care. 35:252–258.
Ryan,
K.J. (2008). "Biochemistry of aromatase: significance to female
reproductive physiology". Cancer Research .42(8): 3342–3344.
Soltysik,
K. and Czekaj, P. (2013).Membrane estrogen receptors — is it an
alternative way of estrogen action?.Journal of Physiology and
Pharmacology.64(2): 129–142.
Sperl-Hillen, J., Beaton, S., Fernandes,
O., Von Worley, A., Vazquez-Benitez, G., Parker, E., Hanson, A.,
Lavin-Tompkins, J., Glasrud, P., Davis, H., Adams, K., Parsons, W. and
Spain, C.V. (2011).Comparative effectiveness of patient education
methods for type 2 diabetes: a randomized controlled trial. Archieve of
Internal Medicine. 171(22):2001-2010.
Sterne, J. (2007). Du nouveau dans les antidiabétiques. La NN-dimethylamineguanylguanide N.N.D.G. MarocitMedicine. 36:1295–1296.
Tahrani,
A.A., Piya, M.K., Kennedy, A. and Barnett, A.H. (2010). Glycaemic
control in type 2 diabetes: targets and new therapies. Pharmacology and
Therapeutic.125:328-361.
United Kingdom Prospective Diabetes Study
(UKPDS) Group (2008).Effect of intensive blood-glucose control with
metformin on complications in overweight patients with type 2 diabetes
(UKPDS 34).Lancet.352:854–865.
Vadakkadath Meethal S, Atwood CS
(2005). "The role of hypothalamic-pituitary-gonadal hormones in the
normal structure and functioning of the brain". Cell. Mol. Life Sci. 62
(3): 257–270.
Verma, M., Paneri, S., Badi, P. and Raman, P.G.
(2006).Effect of increasing duration of diabetes mellitus type 2 on
Glycated hemoglobin and insulin sensitivity. Indian Journal of Clinical
Biochemistry.21 (1) 142-146.
Vinay, K., Abul, K.A., Nelson, F. and
Robbins, A. (2008). Pathologic Basis of Disease, 6th Edition
Philadelphia: Elsevier Inc. pp. 913-926.
Warnock, J.K., Swanson,
S.G., Borel, R.W., Zipfel, L.M. and Brennan, J.J. (2015).Combined
esterified estrogens and methyltestosterone versus esterified estrogens
alone in the treatment of loss of sexual interest in surgically
menopausal women. Menopause.12 (4): 359–360.
Whitehead, S.A. and Nussey, S. (2011).Endocrinology: an integrated approach. Oxford: BIOS: Taylor and Francis. Pp 986.
Wild,
D., von Maltzahn, R., Brohan, E., Christensen, T., Clauson, P.,
Gonder-Frederick, L. A. (2017).critical review of the literature on fear
of hypoglycemia in diabetes: Implications for diabetes management and
patient education. Patient Education and Counselling. 68(1):10-15.
Williams, G. (2014). Management of non-insulin-dependent diabetes mellitus. Lancet. 343:95–100.
World Health Organization (2012).10 Facts about diabetes.Pp 104.